Suppr超能文献

肝细胞移植的新潜在细胞来源:代谢性疾病肝移植中废弃的肝脏。

New potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants.

作者信息

Gramignoli Roberto, Tahan Veysel, Dorko Kenneth, Skvorak Kristen J, Hansel Marc C, Zhao Wenchen, Venkataramanan Raman, Ellis Ewa C S, Jorns Carl, Ericzon Bo-Goran, Rosenborg Staffan, Kuiper Raoul, Soltys Kyle A, Mazariegos George V, Fox Ira J, Wilson Elizabeth M, Grompe Markus, Strom Stephen C

机构信息

Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden.

出版信息

Stem Cell Res. 2013 Jul;11(1):563-73. doi: 10.1016/j.scr.2013.03.002. Epub 2013 Mar 27.

Abstract

UNLABELLED

Domino liver transplantation is a method used to increase the number of liver grafts available for orthotopic liver transplantation (OLT). Reports indicate that livers from patients with metabolic liver disease can be safely transplanted into select recipients if the donor's defect and the recipient's metabolic needs are carefully considered. The liver of patients with many types of metabolic liver disease is morphologically and biochemically normal, except for the mutation that characterizes that disease. Other biochemical functions normally performed by the liver are present and presumably "normal" in these hepatocytes. Hepatocytes were isolated from the liver of 35 organ donors and 35 liver tissues taken at OLT from patients with liver disease were analyzed for 9 different measures of viability and function. The data indicate that cells isolated from some diseased livers performed as well or better than those isolated from organ donors with respect to viability, cell yield, plating efficiency and in assays of liver function, including drug metabolism, conjugation reactions and ammonia metabolism. Cells from metabolic diseased livers rapidly and efficiently repopulated a mouse liver upon transplantation.

CONCLUSIONS

As with domino liver transplantation, domino cell transplantation deserves consideration as method to extend the pool of available organs and cells for transplantation.

摘要

未标注

多米诺肝移植是一种用于增加可用于原位肝移植(OLT)的肝移植物数量的方法。报告表明,如果仔细考虑供体的缺陷和受体的代谢需求,患有代谢性肝病患者的肝脏可以安全地移植给特定受体。除了表征该疾病的突变外,许多类型代谢性肝病患者的肝脏在形态和生化方面是正常的。肝脏通常执行的其他生化功能在这些肝细胞中存在且据推测是“正常的”。从35名器官供体的肝脏中分离出肝细胞,并对从肝病患者OLT手术中获取的35份肝组织进行了9种不同的活力和功能检测。数据表明,就活力、细胞产量、接种效率以及包括药物代谢、结合反应和氨代谢在内的肝功能检测而言,从一些患病肝脏分离出的细胞表现与从器官供体分离出的细胞一样好或更好。代谢性患病肝脏的细胞在移植后能迅速有效地重新填充小鼠肝脏。

结论

与多米诺肝移植一样,多米诺细胞移植作为一种扩大可用于移植的器官和细胞库的方法值得考虑。

相似文献

1
New potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants.
Stem Cell Res. 2013 Jul;11(1):563-73. doi: 10.1016/j.scr.2013.03.002. Epub 2013 Mar 27.
2
Neonatal livers: a source for the isolation of good-performing hepatocytes for cell transplantation.
Cell Transplant. 2014;23(10):1229-42. doi: 10.3727/096368913X669743. Epub 2013 Jun 25.
3
Strategies for short-term storage of hepatocytes for repeated clinical infusions.
Cell Transplant. 2014;23(8):1009-18. doi: 10.3727/096368913X667484.
6
Isolation, characterization and cold storage of cells isolated from diseased explanted livers.
Int J Artif Organs. 2017 Jun 9;40(6):294-306. doi: 10.5301/ijao.5000594. Epub 2017 May 23.
7
Alternative Cell Sources to Adult Hepatocytes for Hepatic Cell Therapy.
Methods Mol Biol. 2017;1506:17-42. doi: 10.1007/978-1-4939-6506-9_2.
10
Explanted diseased livers - a possible source of metabolic competent primary human hepatocytes.
PLoS One. 2014 Jul 7;9(7):e101386. doi: 10.1371/journal.pone.0101386. eCollection 2014.

引用本文的文献

1
2
Effects of Pro-Inflammatory Cytokines on Hepatic Metabolism in Primary Human Hepatocytes.
Int J Mol Sci. 2022 Nov 28;23(23):14880. doi: 10.3390/ijms232314880.
4
General consensus on multimodal functions and validation analysis of perinatal derivatives for regenerative medicine applications.
Front Bioeng Biotechnol. 2022 Oct 3;10:961987. doi: 10.3389/fbioe.2022.961987. eCollection 2022.
5
How Donor and Surgical Factors Affect the Viability and Functionality of Human Hepatocytes Isolated From Liver Resections.
Front Med (Lausanne). 2022 May 11;9:875147. doi: 10.3389/fmed.2022.875147. eCollection 2022.
7
Procurement and Evaluation of Hepatocytes for Transplantation From Neonatal Donors After Circulatory Death.
Cell Transplant. 2022 Jan-Dec;31:9636897211069900. doi: 10.1177/09636897211069900.
8
Liver-humanized mice: A translational strategy to study metabolic disorders.
J Cell Physiol. 2022 Jan;237(1):489-506. doi: 10.1002/jcp.30610. Epub 2021 Oct 18.
9
Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency.
J Inherit Metab Dis. 2021 May;44(3):618-628. doi: 10.1002/jimd.12347. Epub 2020 Dec 30.
10
The concept of "domino" in liver and hepatocyte transplantation.
Therap Adv Gastroenterol. 2020 Oct 24;13:1756284820968755. doi: 10.1177/1756284820968755. eCollection 2020.

本文引用的文献

1
Hepatocyte transplantation using the domino concept in a child with tetrabiopterin nonresponsive phenylketonuria.
Cell Transplant. 2012;21(12):2765-70. doi: 10.3727/096368912X653255. Epub 2012 Aug 10.
2
Development and application of purified tissue dissociation enzyme mixtures for human hepatocyte isolation.
Cell Transplant. 2012;21(6):1245-60. doi: 10.3727/096368911X600939. Epub 2011 Nov 11.
3
Domino liver transplantation: how far can we push the paradigm?
Liver Transpl. 2012 Jan;18(1):22-8. doi: 10.1002/lt.22443.
6
The European experience.
Transpl Int. 2011 Apr;24(4):350-67. doi: 10.1111/j.1432-2277.2011.01225.x. Epub 2011 Jan 26.
7
Liver cell transplantation: basic investigations for safe application in infants and small children.
Cell Transplant. 2009;18(7):777-86. doi: 10.3727/096368909X470775. Epub 2009 Sep 28.
9
Domino liver transplantation: risks and benefits.
Transplant Proc. 2008 May;40(4):1130-1. doi: 10.1016/j.transproceed.2008.03.020.
10
Domino liver transplantation.
J Hepatobiliary Pancreat Surg. 2008;15(2):139-48. doi: 10.1007/s00534-007-1299-1. Epub 2008 Apr 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验